120 likes | 136 Views
Read here the latest updates on the Contrast media injectors market published by the CMI team.<br>
E N D
Coherent Marketing Insights https://www.coherentmarketinsights.com/ Market Research & Business Consulting Services Covid-19 Impact Tracker
CONTRAST MEDIA INJECTORS MARKET ANALYSIS Contrast Media Injectors Market, By Product Type (CT Injectors, MRI Injectors, Cardio Injectors), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Contrast media injectors are devices used to administer or insert contrast media into the patient’s body to enhance visibility of tissues prior to medical imaging procedure such as computed tomography (CT) scan, magnetic resonance imaging (MRI) scan, ultrasound scan, and X-ray. The global contrast media injectors market is estimated to account for US$ 2,000.7 Mn in terms of value and 49,381 units in terms of volume by the end of 2027.
Global Contrast Media Injectors Market: Drivers Increasing prevalence of cancer is expected to boost growth of the global contrast media injectors market over the forecast period. For instance, according to the World Health Organization, cancer is the second leading cause of death worldwide and is resulted in around 9.6 million deaths in 2018. Moreover, increasing investment by government and private organizations in contrast media injectors and treatment and management of chronic diseases is also expected to boost growth of the market. For instance, in December 2019, the Government of Australia announced to invest US$ 5 million in a new funding round for research into the primary and secondary prevention of cancer through the National Health and Medical Research Council's partnership with the Global Alliance for Chronic Diseases.
Figure 1. Global Contrast Media Injectors Market Value (US$ Mn), by Region, 2018
Global Contrast Media Injectors Market: Restraints High cost of contrast media injectors and consumables & accessories is a major factor hindering growth of the global contrast media injectors market over the forecast period. For instance, CT injectors cost between US$ 30,000 and US$ 40,000, while MRI injectors cost between US$ 35,000 and US$ 40,000. Moreover, there are several side effects associated with contrast media such as stomach cramps, nausea, diarrhea and vomiting (associated with barium sulphate contrast materials). Side effects associated with iodine-based contrast materials include, headache, flushing and mild skin rashes. Such side effects are also expected to hamper growth of the market.
Global Contrast Media Injectors Market: Opportunities Key players in the market can focus on developing contrast media injectors with soft bag technology to expand their market share. Use of soft bag technology in contrast media injectors offers several benefits such as gentle media insertion with maximum comfort to patients, easier handling, software-guided protocol, reduced handling time, and reduced chances of formation of air emboli. Moreover, key players in the market can also focus on developing improved software for better contrast media delivery. Software-guided contrast media injectors offer several advantages such as pre-installed protocol, increased accuracy of outcomes, potential increase in contrast media utility, uniform distribution of contrast media, and contrast media management.
Global Contrast Media Injectors Market: Competitive Landscape Major players operating in the global contrast media injectors market include, General Electric, Mallinckrodt, Guerbet SA, Bayer AG, Bracco Imaging S.p.A., Ulrich GmbH & Co. KG, Medtron, and Nemoto Kyorindo Co. Ltd. Global Contrast Media Injectors Market: Key Developments Key players in the market are focused on launching new products to expand their product portfolio. For instance, in November 2019, Bracco Diagnostics Inc. launched new contrast media and device offerings at the 2019 Radiological Society of North America (RSNA) Annual Meeting. In November 2019, General Electric Healthcare launched Serena Bright, a contrast-enhanced mammography solution for biopsy.
Request Sample Report Request Customization Download PDF Brochure Talk to Analyst Referance: https://www.coherentmarketinsights.com/market-insight/contrast-media-injectors-market-3157
About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. What We Provide:Customized Market Research AnalysisIndustry Analysis ServicesBusiness Consulting ServicesLong Term Engagement ModelCountry Specific Analysis
Contact Us Mr. Shah Coherent Market Insights Pvt. LTD.Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S.Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Thank You Kindly Follow CMI Social Media Profiles for the latest Company Updates. Facebook Linkedin Twitter https://www.coherentmarketinsights.com/